The TRanslational Initiative to ​DErisk NeuroTherapeutic (TRIDENT) draws upon research supported by the Government of Canada’s
New Frontiers in Research Fund (NFRF).

Le TRanslational Initiative to ​DErisk NeuroTherapeutic (TRIDENT) repose sur des recherches financées par le fonds Nouvelles frontières en recherche du gouvernement du Canada.

By offering a transformative approach to preclinical evaluation of neurotherapeutics, TRIDENT will dramatically improve the odds of success of  neurotherapeutics in clinical trials for the benefit of humans. across the globe.